Role of heparin and low-molecular-weight heparins in the management of acute ischemic stroke

References

• Teal PS, Pessin MS. Hemorrhagic Transformation: the spectrum of ischemia-related brain hemorrhage. Neurosurg. Clin. N. Am.3, 601–610 (1992).
   PubMedGoogle Scholar
• Cardiogenic brain embolism: the second report of the Cerebral Embolism Task Force. Arch Neurol.46, 727–743 (1989).
   PubMed Web of Science ®Google Scholar
• Hart RG, Boop BS, Tong DC, Yenari MA, Albers GW. Safety of heparin in acute ischemic stroke. Neurology46, 589; 589–591 (1996).
   PubMedGoogle Scholar
• Hart RG, Easton JD. Hemorrhagic infarcts. Stroke17, 586–589 (1986).
   PubMed Web of Science ®Google Scholar
• Koller RL. Recurrent embolic cerebral infarction and anticoagulation. Neurology32, 283–285 (1982).
   PubMed Web of Science ®Google Scholar
• Sacco RL, Foulkes MA, Mohr JP, Wolf PA, Hier DB, Price TR. Determinants of early recurrence of cerebral infarction: the Stroke Data Bank. Stroke20, 983–989 (1989).
   PubMed Web of Science ®Google Scholar
• Moonis M, Fisher M. Considering the role of heparin and low-molecular weight heparins in acute ischemic stroke. Stroke33, 1927–1933 (2002).
   Google Scholar
• The International Stroke Trial (IST): a randomized trial of aspirin, subcutaneous heparin both or neither among 19435 patients with acute ischemic stroke. International Stroke Trial Collaborative group. Lancet349, 1569–1581 (1997).
   PubMed Web of Science ®Google Scholar
• Low-molecular-weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial: the Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. JAMA279, 1265–1272 (1998).
   PubMed Web of Science ®Google Scholar
• Sacco RL, Shi T, Zamanillo MC, Kargiman DE. Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban community; the Northern Manhattan Stroke Study. Neurology44, 626–634 (1994).
   PubMed Web of Science ®Google Scholar
• Berge E, Abdelnoor M, Nakstad PH, Sandset PM. Low molecular-weight heparin versus aspirin in patients with acute ischemic stroke and atrial fibrillation: a double-blind randomised study: HAEST Study Group Heparin in Acute Embolic Stroke Trial. Lancet355, 1205–1210 (2000).
   PubMed Web of Science ®Google Scholar
• CAST (Chinese Acute Stroke Trial). Collaborative group. CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischemic stroke. Lancet349, 1641–1649 (1997).
   PubMed Web of Science ®Google Scholar
• Chen ZM, Sandercock P, Pan HC et al. Indications for early aspirin use in acute ischemic stroke: a combined analysis of 40,000 randomized patients from the Chinese Acute Stroke Trial and the International Stroke Trial. Stroke31, 1240–1249 (2000).
   PubMed Web of Science ®Google Scholar
• Cardiogenic brain embolism. Cerebral Embolism Task Force. Arch Neurol.43(1), 71–84 (1986).
   PubMed Web of Science ®Google Scholar
• Johannessen KA. Peripheral emboli from left ventricular thrombi of different echo cardio graphic appearance in acute myocardial infarction. Arch. Infern. Med.147, 641–644 (1987).
   Google Scholar
• Johannessen KA, Nordelaug JE, von der Lippe G. Prophylactic anticoagulation for LV thrombi after AMI. Am. Heart J.115, 1337–1338 (1988).
   Google Scholar
• Johannessen KA, Nordehaug JE, von der Lippe G, Vollset SE. Risk factors for embolization in patients with left ventricular thrombo and acute myocardial infarction. Br. Heart J.60, 104–110 (1988).
   Google Scholar
• Duke RJ, Bloch RF, Turpe AG, Trebilcock R, Bayer N. Intravenous heparin for the prevention of stroke progression in acute partial stable stroke. Ann. Intern. Med.105(60), 825–828 (1986).
   PubMed Web of Science ®Google Scholar
• Chamorro A, Vila N, Ascaso C, Blane R. Heparin in acute stroke with atrial fibrillation: clinical relevance of very early treatment. Arch Neurol.56(9), 1098–1102 (1999).
   PubMed Web of Science ®Google Scholar
• Daffertshofer M, Grips E, Dempfle CE, Hennerici M. Heparin during acute ischemic stroke. Present data and clinical situation. Nervenarzt74(4), 307–319 (2003).
   Google Scholar
• Bath PMW, Iddenden R, Bath FJ. Low-molecular-weight heparins and heparinoids in acute ischemic stroke. A meta-analysis of randomized controlled trials. Stroke31, 1770–1778 (2000).
   PubMed Web of Science ®Google Scholar
• Hommel M; for the FISS bis Investigators Group. Fraxiparine in ischemic stroke study (FISS bis). Cerebrovasc. Dis. 19: Abstract (1988).
   Google Scholar
• Kay R, Wong KS, Yu YL et al. Low-molecular-weight heparin for the treatment of acute ischemic stroke. N. Engl. J. Med.333, 1588–1593 (1995).
   PubMed Web of Science ®Google Scholar
• Diener HC, Ringlelstein EB, von Kummer R et al. Treatment of acute ischemic stroke with the low-molecular-weight heparin certoparin; results of the TOPAS trial. Stroke32, 22–29 (2001).
   PubMed Web of Science ®Google Scholar
• de Bruijn SFTM, Stam J; for the Cerebral Venous Thrombosis Study Group. Randomized, placebo controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke30, 484–488 (1999).
   PubMed Web of Science ®Google Scholar
• Gubitz G, Consell C, Sandercock P, Signorini D. Anticoagulants for acute ischemic stroke. Cochrane. Database Syst. Rev. (2), CD000024 (2000).
   Google Scholar
• Sandercock P, Mielke O, Liu M, Councsell C. Anticoagulants for preventing recurrence following presumed non-cardioemblic ischemic stroke or transient ischemic attack. Cochrane. Database Syst. Rev. (1), CD 000248 (2003).
   Google Scholar
• Counsell C, Sandercock P. Low-molecular weight heparins or heparinoids versus standard unfractionated heparin for acute ischemic stroke. Cochrane. Database Syst. Rev. (4), CD 000119 (2001).
   Google Scholar
• Berge E, Sandercock P. Anticoagulants versus antiplatelet agents for acute ischemic stroke (Cochrane Review). Cochrane Database Syst. Rev. (2), CD003242 (2001).
   Google Scholar
• Lyrer P, Engelter S. Antithrombotic drugs for carotid artery dissection. Cochrane Database Syst. Rev. (1), CD000255 (2003).
   Google Scholar
• Caplan L. Resolved: heparin may be useful in selected patients with brain ischemia. Stroke34, 230–231 (2003).
   Google Scholar
• Berge E, Adkelnoor M, Nakstad PH, Sandset PM. Low-molecular-weight heparin versus aspirin in patients with acute ischemic stroke and atrial fibrillation: a double-blind randomized study. HAEST Study Group. Heparin in Acute Embolic Stroke Trial. Lancet355, 1205–1210 (2000).
   PubMed Web of Science ®Google Scholar
• Phan TG, Koh M, Wijdicks EFM. Safety of discontinuation of anticoagulation in patients with intracranial hemorrhage at high thromboembolic risk. Arch Neurol.57, 1710–1713 (2000).
   PubMedGoogle Scholar
• Cerebral Embolism Task Force. Cardiogenic rain emblism. Arch Neurol.43, 71–84 (1986).
   PubMed Web of Science ®Google Scholar
• Caplan LR. Worsening in ischemic stroke patients: is it time for a new strategy? Stroke.33, 1443–1445 (2002).
   Google Scholar
• Tong DC, Adam A, Moseley ME, Marks MP. Relationship between diffusion coefficient and subsequent hemorrhagic transformation following acute ischemic stroke. Stroke31, 2378–2384 (2000).
   PubMed Web of Science ®Google Scholar
• Einhaupl KM, Villringer A, Meister W et al. Heparin treatemnt in sinusvenous thrombosis. Lancet338, 597–600 (1991).
   PubMed Web of Science ®Google Scholar
• Meister W, Einhaupl K, Villringer A et al. Treatment of patients with cerebral sinus and vein thrombosis with heparin. In: Cerebral Sinus Thrombosis: Experimental and Clinical Aspects. Einhaupl K, Kempski O, Baethmann A (Eds). Plenum, NY, USA, 225–230 (1990).
   Google Scholar
• de Bruijn SFTM, Stam J; for the Cerebral Venous Sinus Thrombosis Study Group. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular weight heparin for cerebral venous sinus thrombosis. Stroke30, 484–488 (1999).
   PubMed Web of Science ®Google Scholar
• Ameri A, Bousser MG. Cerebral cvenous thrombosis. Neurol. Clin.10, 87–111 (1992).
   PubMed Web of Science ®Google Scholar
• Jacewicz M, Plum F. Aseptic cerebral venous thrombosis. In: Cerebral Sinus Thrombosis: Experimental and Clinical Aspects. Einhaupl K, Kempski O, Baethmann A (Eds). Plenum; NY, USA. 157–170 (1990).
   Google Scholar
• Leizoroviez A, Haugh MC, Chapuis F-R, Samama MM, Boisel J-P. Low-molecular-weight heparin in prevention of perioperative thrombosis. Br. Med. J. 305, 913–920 (1992).
   Google Scholar
• Lensing WA, Prins MH, Davidson BL, Hirsh J. Treatment of deep venous thrombosis with low-molecular-weight heparins: a meta-analysis. Arch. Intern. Med.155, 601–607 (1995).
   PubMed Web of Science ®Google Scholar
• Cohen M, Demers C, Gurfinkel EP et al. The efficacy and safety of subcutaneous enoxaparin in non-Q-wave coronary events study group. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. N. Engl. J. Med.337, 447–452 (1997).
   PubMed Web of Science ®Google Scholar
• Mcarthy ST, Turner J. Low dose subcutaneous heparin in the prevention of deep vein thrombosis and pulmonary emboli following acute stroke. Age Aging.15, 84–88 (1986).
   Google Scholar
• Coull BM, Williams LS, Goldstein LB et al. Anticoagulants and antiplatelet agents in acute ischemic stroke. Stroke33, 1934–1942 (2002).
   PubMed Web of Science ®Google Scholar